Immunotherapy Prolongs Hepatocellular Carcinoma Survival – Medscape
Medscape |
Immunotherapy Prolongs Hepatocellular Carcinoma Survival
Medscape Immunotherapy Prolongs Hepatocellular Carcinoma Survival. Neil Osterweil. April 18, 2018. PARIS — For patients with hepatocellular carcinoma, adjuvant immunotherapy with autologous cytokine-induced killer cells significantly extends 5-year recurrence … |
